Amer Financial Statements From 2010 to 2024

ABMCDelisted Stock  USD 0.01  0  38.00%   
Amer Bio financial statements provide useful quarterly and yearly information to potential Amer Bio Medica investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Amer Bio financial statements helps investors assess Amer Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amer Bio's valuation are summarized below:
Amer Bio Medica does not presently have any fundamental signals for analysis.
Check Amer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amer Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Amer financial statements analysis is a perfect complement when working with Amer Bio Valuation or Volatility modules.
  
This module can also supplement various Amer Bio Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Amer Bio Medica Company Shares Outstanding Analysis

Amer Bio's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Amer Bio Shares Outstanding

    
  48.1 M  
Most of Amer Bio's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amer Bio Medica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Amer Bio Medica has 48.1 M of shares currently outstending. This is 73.36% lower than that of the Health Care Equipment & Supplies sector and 66.29% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 91.59% higher than that of the company.

Amer Bio Medica Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amer Bio's current stock value. Our valuation model uses many indicators to compare Amer Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amer Bio competition to find correlations between indicators driving Amer Bio's intrinsic value. More Info.
Amer Bio Medica is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amer Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amer Bio's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Amer Bio Financial Statements

Amer Bio stakeholders use historical fundamental indicators, such as Amer Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Amer Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amer Bio's assets and liabilities are reflected in the revenues and expenses on Amer Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amer Bio Medica. Please read more on our technical analysis and fundamental analysis pages.
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York. Amer Bio operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 32 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Amer Pink Sheet

If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk